Skip to main content
Signal8

EXELIXIS, INC. (EXEL)

Exelixis, Inc. operates as a biotechnology firm dedicated to combating cancer, primarily focusing on the identification, advancement, and marketing of novel oncological treatments within the United States. Its portfolio of commercially available therapeutics includes CABOMETYX tablets, prescribed for individuals with advanced renal cell carcinoma who have previously undergone anti-angiogenic treatment, and COMETRIQ capsules, utilized for managing progressive and metastatic medullary thyroid cancer. Both CABOMETYX and COMETRIQ originate from cabozantinib, a compound that inhibits several tyrosine kinases such as MET, AXL, RET, and VEGF receptors. Additionally, Exelixis offers COTELLIC, an MEK inhibitor employed in combination therapies for advanced melanoma, and MINNEBRO, an orally administered, non-steroidal selective mineralocorticoid receptor blocker, approved for hypertension treatment in Japan. The company's developmental pipeline features several promising candidates, such as XL092, an oral tyrosine kinase inhibitor designed to target VEGF receptors, MET, AXL, MER, and other kinases crucial for cancer proliferation; XB002, an antibody-drug conjugate containing a human monoclonal antibody against tissue factor (TF), intended for advanced solid tumors and non-Hodgkin's lymphoma; and XL102, an orally available cyclin-dependent kinase 7 (CDK7) inhibitor being developed for advanced or metastatic solid tumors. Exelixis, Inc. maintains extensive research partnerships and licensing arrangements with numerous pharmaceutical and biotechnology entities, including Ipsen Pharma SAS, Takeda Pharmaceutical Company Ltd., F. Hoffmann-La Roche Ltd., Redwood Bioscience, Inc., R.P. Scherer Technologies, LLC, Catalent Pharma Solutions, Inc., NBE Therapeutics AG, Aurigene Discovery Technologies Limited, Iconic Therapeutics, Inc., Invenra, Inc., StemSynergy Therapeutics, Inc., Genentech, Inc., Bristol-Myers Squibb Company, and Daiichi Sankyo Company, Limited. Established in 1994, the company originally operated as Exelixis Pharmaceuticals, Inc. before rebranding to Exelixis, Inc. in February 2000. Its corporate headquarters are located in Alameda, California.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Exelixis, Inc. logo

Exelixis, Inc.

NASDAQ:EXELHealthcare
+4.82%$69.39
AH$69.39+0.00%vs close
Mkt Cap$16.93B
Float240.08M
O/S244.01M
Vol
$ Vol
RVOL
Inst Own-
SI11.4%
Earnings
Dilution
Financials Summary
Revenue$2.32B
Net Income$782.57M
Total Assets$2.84B
Free Cash Flow$844.34M
Debt & Equity
Debt 7%
Equity 93%
Total Debt$173.04M
Total Equity$2.16B
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in EXEL's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$2.84B
Liabilities$683.1M
Accounts Receivable$286.92M
Accounts Payable$29.62M
Inventory$21.69M
PP&E (Net)$441.26M
Goodwill$63.68M
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-01-022025-01-032023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
Revenue$2.32B$2.17B$1.83B$1.61B$1.43B$987.54M$967.77M$853.83M$452.48M$191.45M$37.17M$25.11M$31.34M$47.45M$289.64M$185.04M$151.76M$117.86M$113.47M$98.67M$75.96M$52.86M$51.54M$44.32M$41.01M$24.76M$10.5M$2.27M
YoY Growth7.0%18.5%13.6%12.3%45.3%2.0%13.3%88.7%136.3%415.0%48.0%-19.9%-34.0%-83.6%56.5%21.9%28.8%3.9%15.0%29.9%43.7%2.6%16.3%8.1%65.6%135.8%362.1%-
Cost of Revenue$83.7M$76.22M$72.55M$57.91M$52.87M$36.27M$33.1M$26.35M$15.07M$6.55M$3.9M$2.04M$1.12M$0$0$0$0$0$202K$820K$1.09M$779K$0$0$0-$18.6M-$5.7M$0
Gross Profit$2.24B$2.09B$1.76B$1.55B$1.38B$951.27M$934.68M$827.48M$437.41M$184.9M$33.28M$23.07M$30.22M$47.45M$289.64M$185.04M$151.76M$117.86M$113.27M$97.85M$74.88M$52.08M$51.54M$44.32M$41.01M$43.36M$16.2M$2.27M
Gross Margin96.4%96.5%96.0%96.4%96.3%96.3%96.6%96.9%96.7%96.6%89.5%91.9%96.4%100.0%100.0%100.0%100.0%100.0%99.8%99.2%98.6%98.5%100.0%100.0%100.0%175.1%154.3%100.0%
Research and Development$825M$910.41M$1.04B$891.81M$693.72M$547.85M$336.96M$182.26M$112.17M$95.97M$96.35M$189.1M$178.76M$128.88M$156.84M$210.68M$234.7M$257.39M$225.38M$185.48M$141.13M$137.72M$127.62M$112.01M$82.7M$48.46M$21.7M$12.1M
Selling, General, and Administrative$518.73M$492.13M$542.71M$459.86M$401.71M$293.36M$228.24M$206.37M$159.33M$116.14M$57.3M$50.83M$50.96M$31.84M$33.13M$33.02M$38.96M$36.89M$44.94M$39.12M$27.73M$20.91M$18.59M$18.76M$19.17M$18.91M$7.6M$5.47M
Other$20.51M$85.33M$1-$197K-$184K$912K$680K$397K$0$0$0$0$0$0$0$0$0$41.46M$82.08M$0$0$0$0$0$26.95M$37.76M$13.3M$0
Total Operating Expenses$1.36B$1.49B$1.59B$1.35B$1.1B$841.21M$565.21M$388.62M$271.53M$212.11M$153.66M$239.93M$229.72M$160.72M$189.97M$243.7M$273.67M$298.85M$307.45M$225.42M$169.95M$159.41M$146.87M$131.44M$109.65M$86.22M$35M$17.57M
Operating Income (EBIT)$872.19M$604.62M$170.88M$201.48M$286.67M$110.06M$369.47M$438.86M$165.91M-$28.12M-$121.42M-$224.46M-$200.73M-$122.44M$89.53M-$91.4M-$121.91M-$179.31M-$157.05M-$126.75M-$93.99M-$135.2M-$96.26M-$87.82M-$75.31M-$42.86M-$18.8M-$15.3M
Operating Margin37.6%27.9%9.3%12.5%20.0%11.1%38.2%51.4%36.7%-14.7%-326.6%-893.9%-640.5%-258.0%30.9%-49.4%-80.3%-152.1%-138.4%-128.5%-123.7%-255.8%-186.8%-198.1%-183.7%-173.1%-179.0%-673.2%
Interest Expense$0$0$0$0$0$0$0$0$8.68M$33.06M$40.68M$48.61M$45.35M$27.09M$16.26M$9.34M$12.67M$6.76M$0$0$0$0$0$0$0$0$0$0
Interest Income$69.21M$77.16M$86.54M$33.06M$7.67M$19.86M$27.96M$12.84M$4.88M$2.58M$793K$4.34M$1.22M$1.99M$1.46M$138K$1.51M$5.93M$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)$69.02M$77.02M$86.64M$32.87M$7.49M$20.78M$28.64M$13.24M-$7.33M-$42.1M-$40.27M-$44.27M-$44.12M-$25.1M-$12.54M-$1M-$18.94M$3.74M$46.02M$25.26M-$819K-$2.04M$1.14M$3.29M-$9.36M-$38.09M$0-$370K
Income Before Tax (EBT)$941.21M$681.64M$257.52M$234.35M$294.15M$130.84M$398.11M$452.09M$158.58M-$70.22M-$169.68M-$268.72M-$244.86M-$147.54M$76.99M-$92.4M-$140.84M-$162.85M-$86.38M-$101.49M-$94.81M-$137.25M-$95.12M-$84.53M-$84.68M-$80.96M$0-$15.67M
Income Tax Expense$158.64M$160.37M$49.76M$52.07M$63.09M$19.06M$77.1M-$237.98M$4.35M$0$55K-$182K-$96K$107K$1.29M-$72K-$1.29M-$18.14M-$107.6M$0-$9.59M$0-$345K$345K$2.54M$32.45M-$100K$0
Net Income$782.57M$521.27M$207.76M$182.28M$231.06M$111.78M$321.01M$690.07M$154.23M-$70.22M-$169.74M-$268.54M-$244.76M-$147.65M$75.7M-$92.33M-$135.22M-$162.85M-$86.38M-$101.49M-$84.4M-$137.25M-$94.77M-$86.13M-$71.19M-$75.31M-$18.7M-$15.67M
Net Income Margin33.7%24.0%11.4%11.3%16.1%11.3%33.2%80.8%34.1%-36.7%-456.6%-1069.4%-781.0%-311.2%26.1%-49.9%-89.1%-138.2%-76.1%-102.9%-111.1%-259.7%-183.9%-194.3%-173.6%-304.2%-178.1%-689.5%
Supplementary Data
EPS2.881.800.650.570.730.361.062.320.52-0.28-0.81-1.38-1.33-0.920.60-0.85-1.26-1.54-0.87-1.17-1.07-1.89-1.45-1.52-1.53-2.43-3.17-2.65
Diluted EPS2.781.760.650.560.720.351.022.210.49-0.28-0.81-1.38-1.33-0.920.58-0.85-1.26-1.54-0.87-1.17-1.07-1.89-1.45-1.52-1.53-2.43-4.60-2.65
Weighted Average OS271.57M290.03M318.15M321.53M314.88M308.27M302.58M297.89M293.59M250.53M209.23M194.30M184.03M160.14M126.02M108.52M107.07M105.50M99.15M86.60M78.81M72.50M65.39M56.62M46.48M31.03M5.91M5.91M
EBITDA$921.76M$718.75M$283.24M$255.23M$307.78M$119.2M$406.46M$446.62M$168.3M-$36.16M-$119.6M-$217.73M-$196.36M-$114.73M$100.07M-$72.52M-$115.58M-$155.58M-$157.05M-$109.84M-$70.86M-$89.06M-$77.59M-$70.41M-$53.43M-$24.01M-$13.1M-$15.3M
EBITDA Margin39.7%33.1%15.5%15.8%21.4%12.1%42.0%52.3%37.2%-18.9%-321.8%-867.1%-626.6%-241.8%34.6%-39.2%-76.2%-132.0%-138.4%-111.3%-93.3%-168.5%-150.5%-158.9%-130.3%-97.0%-124.8%-673.2%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-01-022025-01-032023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
Assets
Current Assets
Cash and Cash Equivalents$482.49M$217.37M$262.99M$501.19M$647.17M$319.22M$266.5M$314.77M$183.16M$151.69M$141.63M$80.39M$103.98M$170.07M$74.26M$97.44M$86.8M$247.7M$135.46M$123.37M$96.47M$78.11M$111.83M$84.52M$35.58M$19.55M$5.4M$0
Short-Term Investments$576.6M$893.9M$732.31M$807.27M$819.9M$887.32M$585.74M$378.56M$204.61M$268.12M$25.43M$63.89M$138.47M$241.37M$120M$65.22M$116.29M$14.7M$136.09M$55.52M$67.31M$77.08M$125.26M$131.7M$192.12M$93M$1.5M$0
Cash and Short-Term Investments$1.06B$1.11B$995.3M$1.31B$1.47B$1.21B$852.24M$693.33M$387.77M$419.8M$167.06M$144.28M$242.45M$411.44M$194.26M$162.66M$203.09M$262.4M$271.55M$178.88M$163.78M$155.18M$237.09M$216.23M$227.7M$112.55M$6.9M$0
Accounts Receivable$286.92M$265.44M$237.41M$214.78M$285.55M$160.88M$119.07M$162.77M$81.19M$40.44M$5.18M$4.88M$3.94M$2.75M$30.19M$5.9M$11.86M$1.46M$6.09M$22.2M$7.1M$4.42M$3.85M$3.33M$4.03M$1.49M$200K$0
Inventory$21.69M$22.39M$17.32M$33.3M$27.49M$20.97M$12.89M$9.84M$6.66M$3.34M$2.62M$2.38M$2.89M$0$0$0$0$13K$51K$6.08M$5.44M$0$0$0$0$3.61M$0$0
Other Current Assets$75.6M$68.48M$67.93M$62.21M$54.63M$0$0$0$504K$0$0$12.21M$12.21M$12.25M$0$14.93M$0$0$0$55.09M$34.04M$0$3.16M$3.84M$2.87M$1.99M$900K$0
Total Current Assets$1.44B$1.47B$1.32B$1.62B$1.83B$1.45B$1.01B$897.02M$484.87M$470.8M$178.66M$167.24M$266.61M$432.54M$228.82M$183.49M$230M$271.57M$283.78M$262.25M$210.36M$163.96M$244.09M$223.39M$234.6M$119.64M$8M$0
Long-Term Assets
Property, Plant & Equipment Net$441.26M$359.11M$470.85M$345.44M$104.03M$67.38M$90.73M$56.76M$25.74M$2.07M$1.43M$2.43M$4.91M$6.06M$8.51M$15.81M$29.39M$36.25M$34.66M$32.29M$35.58M$35.46M$33.5M$32.41M$36.5M$23.48M$9.5M$0
Goodwill$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$63.68M$67.36M$67.36M$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$2.6M$3.42M$71.88M$71.5M$72.17M$69.48M$58.67M$0$0
Long-Term Investments$603.6M$637.29M$728.72M$756.73M$371.11M$332.31M$536.38M$157.19M$64.25M$55.6M$83.6M$81.58M$144.3M$182.31M$89.46M$93.71M$17.91M$17.8M$20.7M$19.6M$15M$0$0$0$0$0$0$0
Deferred Tax Assets$292.58M$420.03M$361.14M$231.11M$111.66M$156.71M$172.37M$244.11M$0$0$0$0$0$0$0$0$0-$17.8M-$20.7M-$19.6M-$15M$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$55.77M$131M$71.85M$11.31M$3.52M$16.74M$5.38M$4.96M$13.02M$23.79M$36.5M$2.79M$4.1M$2.43M$30.12M$29.99M$30.9M$15.98M$20.04M$8.7M$11.15M$6.03M$3.12M$1.4M$0
Total Long-Term Assets$1.4B$1.48B$1.62B$1.45B$781.49M$691.94M$874.48M$525.27M$170.42M$126.74M$153.68M$160.72M$236.68M$288.56M$164.44M$177.3M$113.41M$130.05M$128.34M$133.17M$122.35M$127.38M$113.7M$115.72M$112.02M$85.27M$10.9M$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$2.84B$2.95B$2.94B$3.07B$2.62B$2.14B$1.89B$1.42B$655.29M$597.54M$332.34M$327.96M$503.29M$721.1M$393.26M$360.79M$343.41M$401.62M$412.12M$395.42M$332.71M$291.34M$357.79M$339.11M$346.61M$204.91M$18.9M$8.98M
Liabilities
Current Liabilities
Accounts Payable$29.62M$38.19M$33.77M$32.67M$24.26M$23.63M$11.58M$10.9M$9.57M$6.57M$6.4M$6.41M$9.35M$4.4M$1.96M$2.05M$7.4M$4.95M$9.29M$3.7M$1.69M$5.93M$6.15M$4.72M$10.84M$10.05M$3.6M$0
Short-Term Debt$0$0$0$0$0$0$0$0$0$189.12M$0$99.26M$11.76M$13.17M$4.87M$37.75M$39.25M$42.96M$15.77M$13.58M$41.99M$10.86M$9.86M$8.68M$7.15M$6.97M$2.3M$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$7.49M$7.81M$1.79M$6.6M$15.9M$31.98M$19.66M$0$2.58M$1.45M$16.32M$41.92M$100.3M$103.39M$88.94M$64.11M$63.48M$43.48M$28.7M$21.58M$23.79M$12.24M$0$0$0
Other Current Liabilities$287.5M$267.22M$82.12M$71.44M$45.55M$42.66M$15.13M$3.19M$52.54M$33.1M$13.21M$60.25M$52.5M$37.44M$12.91M$0$0$0$0$0$0$0$1.77M$825K$10.14M$7.1M$2.8M$0
Total Current Liabilities$405.64M$403.77M$394.28M$324.36M$337.59M$204.66M$142.75M$105.47M$115.17M$270.59M$52.25M$171.86M$87.85M$81.7M$92.33M$199.94M$207.12M$189.54M$132.88M$111.44M$108.75M$63.8M$54.13M$50.24M$40.36M$24.13M$8.7M$0
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$381.44M$262.39M$335.48M$322.57M$176.65M$170.71M$40.36M$74.72M$105.75M$108.07M$106.86M$136.4M$99.44M$58.97M$30.65M$7.98M$11M$0
Long-Term Unearned Revenue$0$0$0$6.58M$8.74M$3.75M$6.6M$15.9M$238.52M$237.09M$0$0$0$0$16.32M$202.47M$242.33M$171M$63.05M$64.8M$45.33M$32.38M$39.77M$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0-$14.53M$0$0$0$0$0$0$0$0-$171M-$63.05M-$64.8M-$45.33M-$32.38M-$39.77M$0$0$0$0$0
Other Long-Term Liabilities$104.42M$108.89M$94.22M$61.95M$8.02M$721K$2.35M$1.29M$16.64M$541K$2.96M$8.53M$13.72M$20.39M$17.34M$15.99M$17.32M$22.62M$24.92M$20.49M$14.47M$40.38M$40.96M$47.7M$27.24M$9.04M$2M$0
Total Long-Term Liabilities$277.46M$299.72M$284.17M$258.7M$68.03M$53.56M$56.95M$29.36M$255.16M$237.63M$384.39M$270.93M$349.2M$342.96M$210.31M$389.17M$300.02M$268.34M$193.72M$193.37M$166.66M$176.87M$142.19M$112.95M$69.04M$17.01M$13M$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$683.1M$703.49M$678.45M$583.06M$405.62M$258.22M$199.7M$134.83M$370.33M$508.22M$436.65M$442.79M$437.05M$424.66M$302.63M$589.12M$507.13M$457.88M$326.61M$304.81M$275.42M$240.67M$196.31M$163.19M$109.39M$41.14M$21.7M$0
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$46.8M$0
Common Stock$262K$282K$303K$324K$319K$312K$305K$300K$296K$290K$228K$196K$184K$183K$135K$109K$108K$106K$105K$96K$84K$75K$71K$59K$56K$47K$19.5M$0
Retained Earnings-$76.83M-$98.65M-$173.35M-$34.23M-$216.51M-$447.57M-$559.35M-$880.36M-$1.83B-$1.98B-$1.94B-$1.77B-$1.5B-$1.25B-$1.11B-$1.18B-$1.09B-$954.5M-$791.65M-$705.27M-$603.78M-$519.37M-$382.13M-$287.35M-$201.22M-$130.04M-$54.7M-$36.01M
Comprehensive Income & Other$3.48M-$1.35M-$3.75M-$14.52M-$758K$4.48M$3.07M-$701K-$347K-$416K-$232K-$121K$146K-$92K-$138K$12K$155K-$93.7M$499K$1.15M$973K$624K$1.62M-$549K-$5.84M-$11.61M-$14.4M$0
Other Stockholders' Equity$2.24B$2.34B$2.44B$2.52B$2.43B$2.33B$2.25B$2.17B$2.11B$2.07B$1.83B$1.65B$1.56B$1.55B$1.2B$953.62M$925.89M$897.42M$863.63M$757.71M$637.24M$569.97M$543.54M$463.21M$438.39M$292.73M$32.4M$941K
Total Equity$2.16B$2.24B$2.26B$2.49B$2.21B$1.88B$1.69B$1.29B$284.96M$89.32M-$104.3M-$114.83M$66.24M$296.43M$90.63M-$228.32M-$163.72M-$56.98M$72.08M$52.54M$33.54M$50.67M$161.48M$175.92M$237.22M$162.73M-$2.8M-$35.06M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$714K$13.43M$38.07M$23.75M$0$0$0$0$1.04M$0$0
Total Liabilities and Equity$2.84B$2.95B$2.94B$3.07B$2.62B$2.14B$1.89B$1.42B$655.29M$597.54M$332.34M$327.96M$503.29M$721.1M$393.26M$360.79M$343.41M$400.91M$398.69M$357.35M$308.96M$291.34M$357.79M$339.11M$346.61M$203.87M$18.9M-$35.06M
Supplementary Data
Total Debt$173.04M$190.82M$189.94M$190.17M$51.27M$49.09M$50.74M$14.92M$14.53M$189.12M$381.44M$361.66M$347.24M$335.74M$181.51M$208.46M$79.62M$117.68M$121.51M$121.65M$148.85M$147.35M$111.08M$73.93M$48.94M$14.95M$13.3M$0
Net Debt-$309.45M-$26.55M-$73.05M-$311.02M-$595.9M-$270.13M-$215.76M-$299.86M-$168.63M$37.44M$239.8M$281.26M$243.26M$165.67M$107.26M$111.02M-$7.18M-$130.02M-$13.94M-$1.72M$52.38M$69.25M-$744K-$10.59M$13.36M-$4.6M$7.9M$0
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-01-022025-01-032023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Operating Activities
Net Income$782.57M$521.27M$207.76M$182.28M$231.06M$111.78M$321.01M$690.07M$154.23M-$70.22M-$169.74M-$268.54M-$244.76M-$147.65M$75.7M-$92.33M-$139.56M-$162.85M-$86.38M-$101.49M-$84.4M-$137.25M-$94.77M-$86.13M-$71.19M-$75.31M-$18.7M
Depreciation & Amortization$29.05M$28.8M$25.72M$20.88M$13.63M$9.14M$8.35M$7.77M$1.19M$1M$1.41M$2.39M$3.15M$5.72M$6.82M$10.54M$12.6M$13.23M$11.33M$16.91M$17.75M$17.49M$17.75M$16.7M$15.21M$18.86M$5.7M
Deferred Income Tax$126.24M-$59.46M-$133.21M-$60.36M$46.53M$15.27M$71M-$244.11M$3.26M$11.41M$436K-$2.68M$0-$950K-$77.45M-$4.87M$7.77M$0$0-$39.29M-$110K-$56K-$2.46M$0$0$0$0
Stock-Based Compensation$112.98M$93.84M$106.34M$107.57M$119.82M$105.07M$56.6M$44.32M$23.94M$22.91M$21.98M$10.01M$12.03M$8.83M$12.1M$21.11M$22.91M$0$0$17.61M$110K$56K$2.46M$0$0$0$0
Changes in Working Capital:
  Accounts Receivable-$21.4M-$27.95M-$22.62M$66.85M-$122.32M-$42.47M$43.72M-$85.47M-$40.84M-$37M-$646K-$941K$8.49M$27.04M$0$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory$12.22M$5.45M-$12.98M-$11.68M-$13.21M-$21.9M-$5.73M-$3.18M-$3.32M-$722K-$235K$509K-$2.89M$0$0$0$0$0$0$0$0$0$0$0$0$41K$0
  Accounts Payable-$50.15M-$21.89M$50.11M$23.36M$55.09M$50.51M$39.69M$856K$3.01M$164K-$1.28M-$13.21M$8.69M$6.32M-$5.55M-$9.44M$0$0$0$12.16M$355K$764K-$3.38M$0$0$0$0
  Other Working Capital-$131.87M$30.93M-$28.48M-$91.32M$41.43M-$26.28M-$10.59M$8.03M$34.2M$264.83M-$23.69M$3.37M-$16.56M-$14.96M-$259.33M-$32.89M$80.07M$133.3M$46.77M$30.39M$29.57M-$1.71M-$362K$34.84M$15.51M$5.53M$0
Total Working Capital Change-$191.2M-$13.45M-$13.97M-$12.8M-$39.01M-$40.14M$67.08M-$79.76M-$6.95M$227.27M-$25.84M-$10.28M-$2.27M-$8.64M-$264.88M-$42.33M$80.07M$133.3M$46.77M$42.55M$29.92M-$947K-$3.74M$34.84M$15.51M$5.57M$5.7M
Other Non-Cash Items$24.62M$128.98M$140.68M$125.04M$28.77M$7.87M$2.91M-$2.57M-$10.05M$13.93M$30.18M$33.7M$33.08M$19.54M$88.49M$6.83M$1.62M$6.57M-$40.46M$18.37M-$9.63M$26.86M$1.53M$3.66M$16.7M$38.02M$0
Net Cash from Operating$884.27M$699.97M$333.32M$362.61M$400.8M$208.98M$526.96M$415.72M$165.61M$206.3M-$141.59M-$235.41M-$198.77M-$123.15M-$159.23M-$101.05M-$14.59M-$9.76M-$68.74M-$45.34M-$46.36M-$93.84M-$79.24M-$30.92M-$23.77M-$12.87M-$7.3M
Investing Activities
Capital Expenditures-$8.43M-$28.43M-$40.47M-$27.71M-$54.23M-$30.34M-$12.83M-$33.3M-$21.14M-$1.7M-$447K-$474K-$2.17M-$2.72M-$991K-$1.81M-$5.91M-$15.13M-$17.4M-$11.61M-$14.36M-$12.34M-$14.25M-$5.85M-$9.09M-$15.39M-$5M
Acquisitions$0$0$0$0$0$0$0$308K$164K$2.49M$95K$838K$143K$1.94M$3.01M$9M$2.2M$9M$35.31M$10K$186K-$1.6M$0$0$0$0$0
Purchases of Investments-$632.5M-$927.9M-$902.47M-$1.45B-$1.36B-$1.07B-$1.18B-$557.83M-$319.09M-$369.19M-$143.99M-$119.53M-$189.97M-$533.48M-$237.21M-$167.32M-$161.22M-$2.66M-$206.1M-$134.08M-$104.81M-$93.47M-$218.22M-$147.89M-$150.84M-$135.82M-$1.5M
Sales of Investments$1.02B$877.31M$1.04B$1.06B$1.38B$969.4M$608.27M$292.97M$376.86M$153.75M$178.94M$252.89M$325.17M$310.76M$182.21M$140.39M$55.03M$126.94M$182.77M$120.93M$113.6M$139.07M$222.71M$206.31M$156.51M$44.69M$0
Other Investing Activities-$31.5M-$37.75M-$122.5M-$110.75M-$10M$0$0$308K-$1M-$1.4M$15.48M$12.6M$11.18M-$35.99M$1.53M$165K-$2.43M$3.22M$2.4M$3.05M-$30.68M-$11.2M-$4.84M-$5.76M$8.83M$10.08M$0
Net Cash from Investing$350.44M-$116.78M-$26.95M-$524.41M-$42.88M-$131.22M-$587.25M-$297.85M$35.8M-$216.05M$50.08M$146.33M$144.35M-$259.47M-$51.46M-$19.57M-$112.32M$121.37M-$3.02M-$21.7M-$36.07M$20.46M-$14.6M$46.81M$5.41M-$96.44M-$6.5M
Financing Activities
Debt Repaid-------$13K$185.79M$7.71M$4.38M$11.71M$13.17M-$272.8M$6.03M-$125.44M$38.06M$3.83M-$490K$27.2M-$1.49M-$34.54M-$37.1M-$24.8M-$21.43M$2.77M-$8.3M
Common Stock Issuance$49.14M$61.85M$33.45M$23.89M$0$0$0$17.28M$22.42M$27.51M$145.65M$75.64M$0$203.48M$179.38M$3.13M$3.83M$4.15M$83.76M$96.54M$62.44M$5.06M$76.83M$6.83M$12.93M$125.93M$8.9M
Common Stock Repurchases-$947.51M-$652.03M-$550.38M$0$0$0$0-$7.57M-$6.56M-$4.11M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$71.22M-$38.63M-$29.12M-$23.3M-$14.8M-$25.13M$12.55M$9.7M$15.86M$23.41M$0$1.56M$1.5M$2.15M$14.17M$5.82M$248K$310K$0$40M$37M$0$733K$995K$0$297K-$100K
Net Cash from Financing-$969.59M-$628.81M-$546.05M$586K-$14.8M-$25.13M$12.55M$9.69M-$169.93M$19.8M$152.75M$65.49M-$11.67M$478.43M$187.51M$131.26M-$33.99M$630K$84.25M$109.34M$100.93M$39.65M$114.67M$32.63M$34.35M$123.46M$17.1M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$402K-$263K-$137K-$4K$716K$421K$40K$0$0
Net Change in Cash$265.11M-$45.62M-$239.68M-$161.21M$343.12M$52.63M-$47.74M$127.56M$31.48M$10.05M$61.24M-$23.58M-$66.09M$95.81M-$23.18M$10.64M-$160.9M$112.24M$12.09M$42.04M$18.37M-$33.72M$21.55M$48.94M$16.03M$14.15M$3.3M
Supplementary Data
Operating Cash Flow$884.27M$699.97M$333.32M$362.61M$400.8M$208.98M$526.96M$415.72M$165.61M$206.3M-$141.59M-$235.41M-$198.77M-$123.15M-$159.23M-$101.05M-$14.59M-$9.76M-$68.74M-$45.34M-$46.36M-$93.84M-$79.24M-$30.92M-$23.77M-$12.87M-$7.3M
Capital Expenditure-$39.93M-$66.19M-$162.97M-$138.46M-$64.22M-$30.34M-$12.83M-$33.3M-$21.14M-$1.7M-$447K-$474K-$2.17M-$2.72M-$991K-$1.81M-$5.91M-$15.13M-$17.4M-$11.61M-$14.36M-$12.34M-$14.25M-$5.85M-$9.09M-$15.39M-$5M
Free Cash Flow$844.34M$633.79M$170.35M$224.16M$336.58M$178.64M$514.12M$382.42M$144.47M$204.59M-$142.03M-$235.88M-$200.94M-$125.86M-$160.22M-$102.86M-$20.5M-$24.89M-$86.14M-$56.95M-$60.72M-$106.17M-$93.48M-$36.77M-$32.86M-$28.25M-$12.3M
Cash at Beginning$217.37M$262.99M$502.68M$663.89M$320.77M$268.14M$315.88M$188.31M$151.69M$141.63M$80.39M$103.98M$170.07M$74.26M$97.44M$86.8M$247.7M$135.46M$123.37M$81.33M$78.11M$111.83M$90.28M$35.58M$19.55M$5.4M$2.1M
Cash at End$482.49M$217.37M$262.99M$502.68M$663.89M$320.77M$268.14M$315.88M$183.16M$151.69M$141.63M$80.39M$103.98M$170.07M$74.26M$97.44M$86.8M$247.7M$135.46M$123.37M$96.47M$78.11M$111.83M$84.52M$35.58M$19.55M$5.4M